Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro
Authors:
- 1 September 2008
- journal article
- Published by Elsevier in Kidney International
- Vol. 74 (5) , 596-612
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expressionKidney International, 2007
- Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivoKidney International, 2006
- Low calorie commercial sugar is a sensitive marker of glomerular filtration rateKidney International, 2005
- Role of p38 Mitogen-Activated Protein Kinase Activation in Podocyte Injury and Proteinuria in Experimental Nephrotic SyndromeJournal of the American Society of Nephrology, 2005
- Podocyte biology in human diseaseNephrology, 2005
- Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathyKidney International, 2005
- Statins Suppress Oxidized Low Density Lipoprotein-induced Macrophage Proliferation by Inactivation of the Small G Protein-p38 MAPK PathwayJournal of Biological Chemistry, 2005
- Retinoids as a potential treatment for experimental puromycin‐induced nephrosisBritish Journal of Pharmacology, 2003
- A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginineKidney International, 1995
- Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuriaKidney International, 1988